163 related articles for article (PubMed ID: 16581162)
1. 'Combined vaccines are like a sudden onslaught to the body's immune system': parental concerns about vaccine 'overload' and 'immune-vulnerability'.
Hilton S; Petticrew M; Hunt K
Vaccine; 2006 May; 24(20):4321-7. PubMed ID: 16581162
[TBL] [Abstract][Full Text] [Related]
2. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
3. Immune overload: Parental attitudes toward combination and single antigen vaccines.
Hulsey E; Bland T
Vaccine; 2015 May; 33(22):2546-50. PubMed ID: 25891399
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of measles-mumps-rubella vaccine at two different potency levels administered to healthy children aged 12-15 months: A phase III, randomized, non-inferiority trial.
MMR-161 Study Group
Vaccine; 2018 Sep; 36(38):5781-5788. PubMed ID: 30104117
[TBL] [Abstract][Full Text] [Related]
5. Parents' perspectives on the MMR immunisation: a focus group study.
Evans M; Stoddart H; Condon L; Freeman E; Grizzell M; Mullen R
Br J Gen Pract; 2001 Nov; 51(472):904-10. PubMed ID: 11761204
[TBL] [Abstract][Full Text] [Related]
6. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis.
Brown KF; Long SJ; Ramsay M; Hudson MJ; Green J; Vincent CA; Kroll JS; Fraser G; Sevdalis N
Vaccine; 2012 Feb; 30(10):1855-64. PubMed ID: 22230590
[TBL] [Abstract][Full Text] [Related]
7. Addressing issues of vaccination literacy and psychological empowerment in the measles-mumps-rubella (MMR) vaccination decision-making: a qualitative study.
Fadda M; Depping MK; Schulz PJ
BMC Public Health; 2015 Sep; 15():836. PubMed ID: 26328551
[TBL] [Abstract][Full Text] [Related]
8. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
Alfredsson R; Svensson E; Trollfors B; Borres MP
Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
[TBL] [Abstract][Full Text] [Related]
9. The MMR vaccine debate.
Community Nurse; 1998 Oct; 4(9):12-3. PubMed ID: 10326363
[No Abstract] [Full Text] [Related]
10. A combination vaccine against measles, mumps, rubella and varicella.
Knuf M; Faber J; Barth I; Habermehl P
Drugs Today (Barc); 2008 Apr; 44(4):279-92. PubMed ID: 18536786
[TBL] [Abstract][Full Text] [Related]
11. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
12. Children's health and the social theory of risk: insights from the British measles, mumps and rubella (MMR) controversy.
Casiday RE
Soc Sci Med; 2007 Sep; 65(5):1059-70. PubMed ID: 17540488
[TBL] [Abstract][Full Text] [Related]
13. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
[TBL] [Abstract][Full Text] [Related]
14. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
[TBL] [Abstract][Full Text] [Related]
15. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
[TBL] [Abstract][Full Text] [Related]
16. MMR immunisation: what advice should we give to parents?
Rose V
Prof Care Mother Child; 1998; 8(3):58-9. PubMed ID: 9814351
[No Abstract] [Full Text] [Related]
17. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Knuf M; Habermehl P; Zepp F; Mannhardt W; Kuttnig M; Muttonen P; Prieler A; Maurer H; Bisanz H; Tornieporth N; Descamps D; Willems P
Pediatr Infect Dis J; 2006 Jan; 25(1):12-8. PubMed ID: 16395096
[TBL] [Abstract][Full Text] [Related]
18. Parental perspectives of vaccine safety and experience of adverse events following immunisation.
Parrella A; Gold M; Marshall H; Braunack-Mayer A; Baghurst P
Vaccine; 2013 Apr; 31(16):2067-74. PubMed ID: 23422146
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
Leung JH; Hirai HW; Tsoi KK
Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE
J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
